Diagnostics
Backed by Atlas Venture, Lightstone Ventures and OrbiMed, Gemini has emerged with $42.5M in Series A funding and a focus on rare genetic diseases.
The new venture capital fund with a focus on early-stage companies is making waves in the biotech world.
Soldiers are more likely to open up about post-traumatic stress when interviewed by a virtual interviewer than by taking a survey.
The San Francisco Bay Area, and South San Francisco in particular, is a fast-growing area for the biotech industry.
PRESS RELEASES